NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
NervGen Pharma total assets
Total assets on the balance sheet at the end of each period.
NervGen Pharma's total assets was C$23.21M at Dec 31, 2025. For fiscal 2025 it was C$23.21M, up 19.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | C$23.21M | +19.1% |
| FY2024 | Dec 31, 2024 | C$19.49M | +47.2% |
| FY2023 | Jan 1, 2024 | C$13.24M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | C$23.21M | – |
| Q4 FY2024 | Dec 31, 2024 | C$19.49M | – |
| Q4 FY2023 | Jan 1, 2024 | C$13.24M | – |
See a number that looks wrong?